Indian Company Master Data Made Simple
Welcure Drugs And Pharmaceuticals Limited
Profile data last updated: 18/12/2024
Welcure Drugs And Pharmaceuticals Limited, with incorporation dating back to 1996, brings more than 2 decades of expertise. Corporate ID: L24232DL1996PLC227773, registered with number 227773. It falls under the category of company limited by shares. The firm’s authorized share capital totals ₹116.00 crore. Welcure Drugs And Pharmaceuticals Limited reports paid-up capital of ₹112.44 crore.
Its primary business activity involves manufacture of chemicals and chemical products. It is registered in Delhi. Welcure Drugs And Pharmaceuticals Limited is incorporated at Plot No. 55, Office No. 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi , Delhi, East Delhi, New Delhi, New Delhi, Delhi, India, 110092. The company is currently active. For correspondence, the registered email address is [email protected]. The senior leadership includes Altaf Hussain Shah (CFO).
Company Overview
- CIN
- Date of Incorporation
- 06/08/1996
- Company Status
- Active
- RoC
- Delhi
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹1,16,00,00,000.00
- Paid up Capital
- ₹1,12,43,51,500.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹12,319.89L | -₹0.01L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹16,446.77L | ₹3.05L | ₹1.36L | ₹0.38L | ₹0.00L |
| Accumulated Depreciation | -₹4.67L | -₹3.91L | -₹0.32L | ₹0.00L | ₹0.00L |
| Tangible Book Value | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹9.30L | ₹0.00L |
| Long Term Debt | ₹12,319.89L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Machinery Furniture Equipment | ₹7.70L | ₹6.00L | ₹6.00L | ₹0.00L | ₹0.00L |
| Total Assets | ₹26,697.82L | ₹137.10L | ₹152.89L | ₹9.68L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹9.30L | ₹0.00L |
| Total Capitalization | ₹22,570.94L | ₹134.05L | ₹151.53L | ₹9.30L | ₹0.00L |
| Common Stock | ₹11,243.91L | ₹1,343.91L | ₹1,343.91L | ₹1,211.86L | ₹0.00L |
| Total Debt | ₹12,319.89L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Equity Interest | -₹992.86L | -₹1,209.87L | ₹0.00L | -₹1,202.56L | -₹1,204.91L |
| Capital Stock | ₹11,243.91L | ₹1,343.91L | ₹1,343.91L | ₹1,211.86L | ₹0.00L |
| Invested Capital | ₹22,570.94L | ₹134.05L | ₹151.53L | ₹9.30L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹12.82L | ₹2.16L | ₹0.12L | ₹6.60L | ₹0.00L |
| Total Non Current Assets | ₹8,483.72L | ₹133.91L | ₹152.30L | ₹3.08L | ₹0.00L |
| Net Tangible Assets | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹9.30L | ₹0.00L |
| Prepaid Assets | ₹1,951.86L | ₹1.02L | ₹0.47L | ₹0.00L | ₹0.00L |
| Cash And Cash Equivalents | ₹12.83L | ₹2.16L | ₹0.12L | ₹6.60L | ₹0.00L |
| Stockholders Equity | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹9.30L | ₹0.00L |
| Other Short Term Investments | ₹1,950.84L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Share Issued | ₹1,125.12L | ₹135.12L | ₹135.12L | ₹135.12L | ₹0.00L |
| Current Assets | ₹18,214.11L | ₹3.18L | ₹0.59L | ₹6.60L | ₹0.00L |
| Net Debt | ₹12,307.06L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Working Capital | ₹14,087.23L | ₹0.12L | -₹0.77L | ₹6.22L | ₹0.00L |
| Ordinary Shares Number | ₹1,125.12L | ₹135.12L | ₹135.12L | ₹135.12L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹12,319.89L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Liabilities | ₹4,126.88L | ₹3.06L | ₹1.36L | ₹0.38L | ₹0.00L |
| Net PPE | ₹3.03L | ₹2.09L | ₹5.68L | ₹0.00L | ₹0.00L |
| Other Non Current Assets | ₹7.73L | ₹0.01L | ₹0.00L | ₹3.08L | ₹0.00L |
| Common Stock Equity | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹9.30L | ₹0.00L |
| Inventory | ₹14,352.36L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Changes In Cash | ₹10.66L | ₹2.03L | -₹6.48L | ₹1.86L |
| Financing Cash Flow | ₹22,219.89L | -₹1.71L | -₹17.17L | ₹0.00L |
| Free Cash Flow | -₹22,204.58L | -₹12.76L | ₹10.69L | ₹1.86L |
| Investing Cash Flow | -₹6.35L | ₹16.50L | ₹0.00L | ₹0.00L |
| End Cash Position | ₹12.83L | ₹2.16L | ₹0.12L | ₹6.60L |
| Other Cash Adjustment Outside Changein Cash | ₹0.01L | ₹0.01L | ₹0.00L | -₹0.01L |
| Capital Expenditure | -₹1.70L | ₹0.00L | ₹0.00L | ₹0.00L |
| Beginning Cash Position | ₹2.16L | ₹0.12L | ₹6.60L | ₹4.75L |
| Operating Cash Flow | -₹22,202.88L | -₹12.76L | ₹10.69L | ₹1.86L |
| Issuance Of Capital Stock | ₹9,900.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | ₹217.01L | -₹17.48L | ₹10.17L | ₹2.36L | ₹0.00L |
| Basic EPS | ₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹278.77L | -₹22.79L | ₹10.49L | ₹2.36L | ₹0.00L |
| Total Expenses | ₹2,367.98L | ₹26.38L | ₹13.54L | ₹8.14L | ₹0.00L |
| Operating Revenue | ₹2,455.00L | ₹0.00L | ₹0.00L | ₹10.50L | ₹0.00L |
| Total Unusual Items | ₹0.00L | -₹0.32L | ₹19.27L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | ₹19.27L | ₹0.00L | ₹0.00L |
| Interest Income Non Operating | ₹0.00L | ₹5.79L | ₹4.44L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹217.01L | -₹17.48L | ₹10.17L | ₹2.36L | ₹0.00L |
| General And Administrative Expense | ₹201.78L | ₹4.73L | ₹2.72L | ₹1.61L | ₹0.00L |
| Reconciled Depreciation | ₹0.76L | ₹3.59L | ₹0.32L | ₹0.00L | ₹0.00L |
| Net Income Continuous Operations | ₹217.01L | -₹17.48L | ₹10.17L | ₹2.36L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹2,050.34L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹217.01L | -₹17.48L | ₹10.17L | ₹2.36L | ₹0.00L |
| Operating Income | ₹96.14L | -₹26.38L | -₹13.54L | ₹2.36L | ₹0.00L |
| Diluted Average Shares | ₹780.66L | ₹135.12L | ₹134.39L | ₹121.19L | ₹0.00L |
| Normalized Income | ₹217.01L | -₹17.16L | -₹9.10L | ₹2.36L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹0.00L | ₹5.78L | ₹4.43L | -₹0.01L | ₹0.00L |
| EBIT | ₹278.01L | -₹26.38L | ₹10.17L | ₹2.36L | ₹0.00L |
| Gross Profit | ₹404.66L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cost Of Revenue | ₹2,050.34L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹217.01L | -₹17.48L | ₹10.17L | ₹2.36L | ₹0.00L |
| Net Interest Income | -₹8.95L | ₹0.00L | ₹4.43L | -₹0.01L | ₹0.00L |
| Operating Expense | ₹317.64L | ₹26.38L | ₹13.54L | ₹8.14L | ₹0.00L |
| Normalized EBITDA | -₹94.09L | -₹22.47L | -₹8.78L | ₹2.36L | ₹0.00L |
| Net Income Common Stockholders | ₹217.01L | -₹17.48L | ₹10.17L | ₹2.36L | ₹0.00L |
| Pretax Income | ₹278.01L | -₹17.48L | ₹10.17L | ₹2.36L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹2,455.00L | ₹0.00L | ₹0.00L | ₹10.50L | ₹0.00L |
| Selling General And Administration | ₹205.04L | ₹4.73L | ₹2.93L | ₹1.61L | ₹0.00L |
| Other Operating Expenses | ₹289.23L | ₹6.54L | ₹6.06L | ₹5.00L | ₹0.00L |
| Diluted EPS | ₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹1,125.12L | ₹135.12L | ₹134.39L | ₹121.19L | ₹0.00L |
| Tax Provision | ₹61.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹217.01L | -₹17.48L | ₹10.17L | ₹2.36L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 22/10/2022 | Manowar Ali | *****8323P | Company Secretary | |
| 14/11/2023 | Altaf Hussain Shah | 10351528 | Managing Director | View other directorships |
| 14/11/2023 | Suraj Chagan Solanki | 10380845 | Director | View other directorships |
| 14/02/2024 | Deepika Krishnan Iyer | 10515778 | Director | View other directorships |
| 14/02/2024 | Altaf Hussain Shah | *****3074E | CFO | |
| 04/10/2024 | Pradeep Dnyaneshwar Terse | 10758084 | Additional Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 09/12/2024 | Form AOC-4(XBRL)-29102024 | - |
| 27/11/2024 | Form MGT-7-27112024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Plot No. 55, Office No. 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi , Delhi, East Delhi, New Delhi, New Delhi, Delhi, India, 110092
Frequently Asked Questions
What is the incorporation date of Welcure Drugs And Pharmaceuticals Limited?
The incorporation date of Welcure Drugs And Pharmaceuticals Limited is 06/08/1996.
What is the authorized share capital and paid-up capital of Welcure Drugs And Pharmaceuticals Limited?
The authorized share capital of Welcure Drugs And Pharmaceuticals Limited is ₹1,16,00,00,000.00. The paid-up capital is ₹1,12,43,51,500.00.
Who are the current board members & directors of Welcure Drugs And Pharmaceuticals Limited?
The current board member of Welcure Drugs And Pharmaceuticals Limited are:
- Altaf Hussain Shah
- Suraj Chagan Solanki
- Pradeep Dnyaneshwar Terse
- Deepika Krishnan Iyer
What is the registered address of Welcure Drugs And Pharmaceuticals Limited?
The registered address of Welcure Drugs And Pharmaceuticals Limited is Plot No. 55, Office No. 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi , Delhi, East Delhi, New Delhi, New Delhi, Delhi, India, 110092.
What is the Corporate Identification Number of Welcure Drugs And Pharmaceuticals Limited?
The Corporate Identification Number of Welcure Drugs And Pharmaceuticals Limited is L24232DL1996PLC227773.